# Dystrogen Therapeutics Corp — Form D

Dystrogen Therapeutics Corp of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2019-08-07. The offering totals $5.0M, of which $1.1M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2019-08-07
- Form: D
- Accession: 0001778074-19-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.1M
- Remaining: $3.9M
- Minimum investment: $85
- Investors: 14
- Date of first sale: 2019-08-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-346014

## Issuer

- Name: Dystrogen Therapeutics Corp
- CIK: 0001778074
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1415 W. 37TH STREET, CHICAGO, IL, 60609
- Phone: 2164101829

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Kris Siemionow | Director | Chicago, IL |

## More

- [CIK 1778074 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1778074&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001778074-19-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.